Thomas G. Auchincloss, Director at CONCERT PHARMACEUTICALS, INC. (CNCE), bought 6,000 shares at $4.75 ($29K) on 2022-06-06, disclosed to the SEC on 2022-06-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CNCE | BUY | 2018-11-19 | $12K | — | Filing → |
| CNCE | BUY | 2018-11-15 | $12K | — | Filing → |
| CNCE | BUY | 2016-05-16 | $20K | — | Filing → |